Litigation Details for Genentech, Inc. v. Amgen Inc. (D. Del. 2018)
✉ Email this page to a colleague
Genentech, Inc. v. Amgen Inc. (D. Del. 2018)
| Docket | ⤷ Try a Trial | Date Filed | 2018-06-21 |
| Court | District Court, D. Delaware | Date Terminated | 2020-07-07 |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | Plaintiff | Referred To | Sherry R. Fallon |
| Parties | CITY OF HOPE | ||
| Patents | 6,194,006; 6,316,462; 7,449,184; 7,575,768; 8,512,983; 8,691,232; 9,714,293 | ||
| Attorneys | Adam R. Lawton | ||
| Firms | Young, Conaway, Stargatt & Taylor LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Genentech, Inc. v. Amgen Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Biologic Drugs cited in Genentech, Inc. v. Amgen Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Genentech, Inc. v. Amgen Inc. (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-07-26 | Exchange Opening Expert Reports for U.S. Patent Nos. 8,512,983 and 9,714,293 to August 2, 2019 filed by… 2018 7 July 2020 1:18-cv-00924 830 Patent Plaintiff District Court, D. Delaware | External link to document | ||
| 2018-07-02 | 10 | Redacted Document | assignment of the ’122 patent. 62. U.S. Patent No. 7,449,184 (“the ’184 patent”), titled “Fixed…with Perjeta 60. U.S. Patent Nos. 7,501,122, 7,449,184, and 8,691,232 claim novel therapies… INFRINGEMENT OF U.S. PATENT NO. 7,449,184 190. Plaintiffs incorporate…: U.S. Patent No. 6,331,415, U.S. Patent No. 7,923,221, U.S. Patent No. 6,407,213, U.S. Patent No. 7,…, U.S. Patent No. 7,892,549, U.S. Patent No. 6,627,196, U.S. Patent No. 7,371,379, U.S. Patent No. 6, | External link to document |
| 2019-06-14 | 256 | Opinion - Memorandum Opinion | quot;the '066 patent"); 8,574,869 ("the '869 patent"); 8,512,983 ("the '…of terms set forth in U.S. Patent Nos. 7,993,834 ("the '834 patent"); 8,076,066 ("…#x27;983 patent"); and 7,390,660 ("the '660 patent"). D.I. 60; D.I. 121. 1 …quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which …clauses of both patents were added by Genentech in response to same objection by the patent examiner. Compare | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
